StonvexLoading…
StonvexCore line items from MAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.35B | $5.38B | $5.44B | $5.43B |
Operating Income | $546.42M | $694.28M | $561.66M | $675.51M |
Net Income | $397.58M | $541.82M | $214.35M | $393.91M |
EPS (Diluted) | $1.24 | $1.58 | $0.60 | $1.10 |
Total Assets | $6.64B | $6.54B | $6.44B | $6.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.24B | $1.39B | $1.26B | $761.24M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 321.79M | 343.34M | 357.11M | 359.61M |